Clinerion Launches Machine Learning Platform
Clinerion launched its Federated Machine Learning Platform, a global, federated machine learning (ML) platform on its Patient Network Explorer infrastructure, incorporating its global network of partner hospitals. This new platform will enable analytics and pattern recognition use cases on real-world data (RWD) across the Patient Network Explorer network.
Read more about the platform here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
